Kintegral Advisory’s Zimmer Biomet ZBH Stock Holding History

Kintegral Advisory’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.04M	Sell	11,426 -507	-4%	-$46.5K	0.1%	167
2025 Q4	$1.08M	Sell	11,933 -327	-3%	-$31K	0.09%	167
2025 Q3	$1.21M	Sell	12,260 -55	-0.4%	-$5.45K	0.1%	164
2025 Q2	$1.13M	Sell	12,315 -18	-0.1%	-$1.74K	0.1%	171
2025 Q1	$1.4M	Sell	12,333 -42	-0.3%	-$4.49K	0.14%	148
2024 Q4	$1.31M	Sell	12,375 -576	-4%	-$61.8K	0.12%	159
2024 Q3	$1.4M	Sell	12,951 -170	-1%	-$18.6K	0.13%	153
2024 Q2	$1.43M	Buy	13,121 +1,407	+12%	+$166K	0.14%	151
2024 Q1	$1.55M	Sell	11,714 -37	-0.3%	-$4.62K	0.15%	131
2023 Q4	$1.43M	Buy	+11,751	New	+$1.31M	0.16%	136
2019 Q1	–	Sell	-2,104	Closed	-$212K	–	300
2018 Q4	$212K	Buy	+2,104	New	+$237K	0.06%	217

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kintegral Advisory's ZBH Position: Q1 2026 in Review

Kintegral Advisory reduced its Zimmer Biomet (ZBH) stake by 4.2% in Q1 2026, selling an estimated $46.5K and leaving 11,426 shares worth $1.04M. The position accounts for 0.1% of the portfolio, ranked #167.

Kintegral Advisory first reported a position in ZBH in Q4 2018 and has held it in 11 quarters since. The position peaked at $1.55M in Q1 2024. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Kintegral Advisory held 11,426 shares of Zimmer Biomet worth $1.04M as of Q1 2026.
Kintegral Advisory sold 507 Zimmer Biomet shares in Q1 2026, an estimated $46.5K.
Zimmer Biomet made up 0.1% of Kintegral Advisory's portfolio in Q1 2026, its #167 holding.
Kintegral Advisory first reported a position in Zimmer Biomet in Q4 2018 and has held it in 11 quarters since.
Kintegral Advisory's Zimmer Biomet position peaked at $1.55M in Q1 2024.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Kintegral Advisory's 13F filing for Q1 2026, filed 14 May 2026.